Consolidated Statements of Cash Flows (USD $)	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Cash Flows From Operating Activities:
Net loss	$ (6,536,955)	$ (2,417,107)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	14,200	73,583
Share-based compensation	286,508	99,412
Fair value of common stock issued for charitable contributions	0	113,400
Fair value of common stock and warrants issued for services	380,763	901,393
Fair value of options issued for services	0	46,109
Derivative warrant liability loss (gain)	3,151,908	(671,936)
Non-cash gain on extinguishment of financial advisor fee payable	0	(200,000)
Non-cash loss on extinguishment of debt	1,514	0
Non-cash interest expense	12,159	0
Non-cash loss on disposal of assets	2,731	0
Changes in assets and liabilities:
Accounts receivable	104,423	65,421
Stock subscriptions receivable	285,000	0
Prepaid expenses and other current assets	(83,602)	(95,621)
Accounts payable	(175,345)	(490,707)
Deferred revenue	(242,910)	(181,571)
Accrued expenses and other liabilities	207,238	(100,356)
Deposits and other assets	(10,566)	2,000
Net cash used in operating activities	(2,602,934)	(2,855,980)
Cash Flows from Investing Activities:
Purchases of property and equipment	(249,127)	(3,057)
Increase in restricted cash	(128,250)	0
Net cash (used in) investing activities	(377,377)	(3,057)
Cash Flows From Financing Activities:
Proceeds from the exercise of warrants	576,224	0
Proceeds from issuance of common stock and warrants, net of expenses	794,761	2,311,157
Principal payments for capital lease obligations	(1,009)	(914)
Proceeds from issuance of Series D Convertible Preferred Stock, net of expenses	2,478,702	0
Proceeds from bridge notes	1,000,000	0
Repayment of bridge notes	(75,000)	0
Proceeds from exercise of stock options, net of forfeitures	64,250	0
Net cash provided by financing activities	4,837,928	2,310,243
Net increase (decrease) in cash and cash equivalents	1,857,617	(548,794)
Cash and cash equivalents, beginning of period	1,342,044	1,166,858
Cash and cash equivalents, end of period	3,199,661	618,064
Supplemental Disclosure of Cash Flow Information and Non Cash Financing Transactions:
Cash paid for interest	1,196	1,707
Accretion of dividend on Series B Perpetual Redeemable Preferred Stock	93,242	56,674
Deemed dividend on beneficial conversion feature of Series D Convertible Preferred Stock	1,975,211	0
Issuance of common stock in settlement of short term note	25,000	0
Conversion of notes payable and accrued interest into Series D Convertible Preferred Stock	1,006,000	0
Reclassification of derivative warrant liability to additional paid-in capital	2,170,727	200,357
Fair value of warrants issued for investor relations services	173,000	0
Fair value of common stock issued for short-term note extension	10,500	0
Fair value of warrants issued to financial advisors as financing costs	41,363	217,141
Cancellation of restricted Common Stock	$ 5,250	$ 0